192 related articles for article (PubMed ID: 34435590)
21. Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats.
Khaksar S; Bigdeli M; Samiee A; Shirazi-Zand Z
Brain Res Bull; 2022 Mar; 180():118-130. PubMed ID: 35031355
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
[TBL] [Abstract][Full Text] [Related]
23. Cannabidiol, neuroprotection and neuropsychiatric disorders.
Campos AC; Fogaça MV; Sonego AB; Guimarães FS
Pharmacol Res; 2016 Oct; 112():119-127. PubMed ID: 26845349
[TBL] [Abstract][Full Text] [Related]
24. Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid.
Kozela E; Juknat A; Vogel Z
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788104
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
27. Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
Liu P; Cui L; Liu B; Liu W; Hayashi T; Mizuno K; Hattori S; Ushiki-Kaku Y; Onodera S; Ikejima T
Physiol Behav; 2020 Jan; 213():112689. PubMed ID: 31669775
[TBL] [Abstract][Full Text] [Related]
28. From
Cassano T; Villani R; Pace L; Carbone A; Bukke VN; Orkisz S; Avolio C; Serviddio G
Front Pharmacol; 2020; 11():124. PubMed ID: 32210795
[No Abstract] [Full Text] [Related]
29. Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.
Santiago AN; Mori MA; Guimarães FS; Milani H; Weffort de Oliveira RM
Neurotox Res; 2019 Feb; 35(2):463-474. PubMed ID: 30430393
[TBL] [Abstract][Full Text] [Related]
30. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
Holland WL; Summers SA
Endocr Rev; 2008 Jun; 29(4):381-402. PubMed ID: 18451260
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
Tambe SM; Mali S; Amin PD; Oliveira M
J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
[TBL] [Abstract][Full Text] [Related]
32. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
[TBL] [Abstract][Full Text] [Related]
33. Sphingolipids in High Fat Diet and Obesity-Related Diseases.
Choi S; Snider AJ
Mediators Inflamm; 2015; 2015():520618. PubMed ID: 26648664
[TBL] [Abstract][Full Text] [Related]
34. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT
Echeverry C; Prunell G; Narbondo C; de Medina VS; Nadal X; Reyes-Parada M; Scorza C
Neurotox Res; 2021 Apr; 39(2):335-348. PubMed ID: 32886342
[TBL] [Abstract][Full Text] [Related]
35. Metformin treatment affects adipocytokine secretion and lipid composition in adipose tissues of diet-induced insulin-resistant rats.
Grycel S; Markowski AR; Hady HR; Zabielski P; Kojta I; Imierska M; Górski J; Blachnio-Zabielska AU
Nutrition; 2019; 63-64():126-133. PubMed ID: 30959381
[TBL] [Abstract][Full Text] [Related]
36. Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors.
Ibork H; Idrissi SE; Zulu SS; Miller R; Hajji L; Morgan AM; Taghzouti K; Abboussi O
Neurotox Res; 2023 Dec; 41(6):615-626. PubMed ID: 37782433
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs.
Balbaa M; Abdulmalek SA; Khalil S
PLoS One; 2017; 12(5):e0172429. PubMed ID: 28505155
[TBL] [Abstract][Full Text] [Related]
39. New role for ceramide in hypoxia and insulin resistance.
Xia QS; Lu FE; Wu F; Huang ZY; Dong H; Xu LJ; Gong J
World J Gastroenterol; 2020 May; 26(18):2177-2186. PubMed ID: 32476784
[TBL] [Abstract][Full Text] [Related]
40. Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway.
Wang H; Sun X; Zhang N; Ji Z; Ma Z; Fu Q; Qu R; Ma S
Physiol Behav; 2017 Dec; 182():93-100. PubMed ID: 28988132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
